Concepedia

Edmund Poon

EP

Statistics

Publications

12

Citations

2.6K

H-Index

11

Active since

2008

Affiliations

Aimmune Therapeutics (United Kingdom)(Current)

AstraZeneca (United Kingdom)

Great Ormond Street Hospital

Granta Design (United Kingdom)

Altimmune (United States)

Edmund Poon is an author at Aimmune Therapeutics (United Kingdom) specializing in immunology, oncology, and cancer immunotherapy.

ORCID

Publications per year

2008–2022

12

Publications

12

Acquired Resistance to Fractionated Radiotherapy Can Be Overcome by Concurrent PD-L1 Blockade

Simon J. Dovedi, Amy L. Adlard, Grazyna Lipowska‐Bhalla et al. · Cancer Research · 2014 · 1.3K citations · Full text

, , +17

Identification and Characterization of MEDI4736, an Antagonistic Anti–PD-L1 Monoclonal Antibody

Ross Stewart, Michelle Morrow, Scott A. Hammond et al. · Cancer Immunology Research · 2015 · 409 citations

, , +17

Fractionated Radiation Therapy Stimulates Antitumor Immunity Mediated by Both Resident and Infiltrating Polyclonal T-cell Populations when Combined with PD-1 Blockade

Simon J. Dovedi, Eleanor J. Cheadle, Amy L. Popple et al. · Clinical Cancer Research · 2017 · 367 citations · Full text

, , +17

Targeting CD73 in the tumor microenvironment with MEDI9447

Carl Hay, Erin Sult, Qihui Huang et al. · OncoImmunology · 2016 · 288 citations · Full text

, , +17

The MEK inhibitor selumetinib complements CTLA-4 blockade by reprogramming the tumor immune microenvironment

Edmund Poon, Stefanie Mullins, Amanda Watkins et al. · Journal for ImmunoTherapy of Cancer · 2017 · 75 citations · Full text

, , +17

1–5 of 12